Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuances
Ratios

Lifecore Biomedical (LFCR) Short-Term Debt issuances: 2014-2025

Historic Short-Term Debt issuances for Lifecore Biomedical (LFCR) over the last 9 years, with Feb 2025 value amounting to -$6.0 million.

  • Lifecore Biomedical's Short-Term Debt issuances fell 297.69% to -$6.0 million in Q1 2025 from the same period last year, while for Feb 2025 it was $129.3 million, marking a year-over-year increase of 120.81%. This contributed to the annual value of $149.6 million for FY2024, which is 375.63% up from last year.
  • Lifecore Biomedical's Short-Term Debt issuances amounted to -$6.0 million in Q1 2025, which was up 54.22% from -$13.1 million recorded in Q4 2024.
  • Lifecore Biomedical's Short-Term Debt issuances' 5-year high stood at $146.5 million during Q2 2024, with a 5-year trough of -$32.0 million in Q1 2023.
  • Moreover, its 3-year median value for Short-Term Debt issuances was $1.9 million (2024), whereas its average is $17.3 million.
  • In the last 5 years, Lifecore Biomedical's Short-Term Debt issuances surged by 449.01% in 2023 and then crashed by 492.45% in 2024.
  • Over the past 5 years, Lifecore Biomedical's Short-Term Debt issuances (Quarterly) stood at $18.0 million in 2021, then slumped by 77.78% to $4.0 million in 2022, then plummeted by 155.30% to -$2.2 million in 2023, then tumbled by 492.45% to -$13.1 million in 2024, then slumped by 297.69% to -$6.0 million in 2025.
  • Its last three reported values are -$6.0 million in Q1 2025, -$13.1 million for Q4 2024, and $1.9 million during Q3 2024.